Fusion Pharmaceuticals Inc. Pre-Tax Income
Fusion Pharmaceuticals Inc. reported Pre-Tax Income of -$94.11 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2024-03-20
- Fusion Pharmaceuticals Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-12-31 was -$24.96M.
- Fusion Pharmaceuticals Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-09-30 was -$24.77M.
- Fusion Pharmaceuticals Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-06-30 was -$19.75M.
- Fusion Pharmaceuticals Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2022-03-31 was -$19.96M.
- Fusion Pharmaceuticals Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$94.11M.
- Fusion Pharmaceuticals Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$89.45M.
- Fusion Pharmaceuticals Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$81.17M.
- Fusion Pharmaceuticals Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$75.72M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$94.11M 10-K · filed 2024-03-20 | |||
| 2022-12-31 | -$24.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | -$49.73M derived: sum of 2 quarters · filed 2024-03-20 | -$69.48M derived: sum of 3 quarters · filed 2024-03-20 | -$89.45M 10-K · filed 2024-03-20 |
| 2022-09-30 | -$24.77M 10-Q · filed 2022-11-08 | -$44.53M derived: sum of 2 quarters · filed 2022-11-08 | -$64.49M 10-Q · filed 2022-11-08 | -$81.90M derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-06-30 | -$19.75M 10-Q · filed 2022-08-09 | -$39.72M 10-Q · filed 2022-08-09 | -$57.13M derived: sum of 3 quarters · filed 2023-03-16 | -$76.51M derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-03-31 | -$19.96M 10-Q · filed 2022-05-10 | -$37.37M derived: sum of 2 quarters · filed 2023-03-16 | -$56.75M derived: sum of 3 quarters · filed 2023-03-16 | -$83.59M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-12-31 | -$17.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$36.79M derived: sum of 2 quarters · filed 2023-03-16 | -$63.63M derived: sum of 3 quarters · filed 2023-03-16 | -$81.17M 10-K · filed 2023-03-16 |
| 2021-09-30 | -$19.38M 10-Q · filed 2022-11-08 | -$46.22M derived: sum of 2 quarters · filed 2022-11-08 | -$63.76M 10-Q · filed 2022-11-08 | -$74.56M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$26.84M 10-Q · filed 2022-08-09 | -$44.38M 10-Q · filed 2022-08-09 | -$55.18M derived: sum of 3 quarters · filed 2022-08-09 | -$65.35M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$17.54M 10-Q · filed 2022-05-10 | -$28.34M derived: sum of 2 quarters · filed 2022-05-10 | -$38.52M derived: sum of 3 quarters · filed 2022-05-10 | -$83.10M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$20.98M derived: sum of 2 quarters · filed 2022-03-17 | -$65.56M derived: sum of 3 quarters · filed 2022-03-17 | -$75.72M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$10.18M 10-Q · filed 2021-11-09 | -$54.76M derived: sum of 2 quarters · filed 2021-11-09 | -$64.92M 10-Q · filed 2021-11-09 | -$73.09M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$44.58M 10-Q · filed 2021-08-10 | -$54.74M 10-Q · filed 2021-08-10 | -$62.91M derived: sum of 3 quarters · filed 2021-08-10 | -$63.32M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$10.16M 10-Q · filed 2021-05-11 | -$18.33M derived: sum of 2 quarters · filed 2021-05-11 | -$18.74M derived: sum of 3 quarters · filed 2021-05-11 | -$22.18M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$8.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$8.58M derived: sum of 2 quarters · filed 2021-03-25 | -$12.02M derived: sum of 3 quarters · filed 2021-03-25 | -$15.94M 10-K · filed 2021-03-25 |
| 2019-09-30 | -$413.00K 10-Q · filed 2020-11-10 | -$3.85M derived: sum of 2 quarters · filed 2020-11-10 | -$7.77M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$3.44M 10-Q · filed 2020-08-11 | -$7.36M 10-Q · filed 2020-08-11 |